TabsDetailsBasic DetailsDate Posted: Wednesday, March 7, 2018Status: CompleteMedical Product: rivaroxabanDescription: This report investigates exposure to rivaroxaban among all patients in the Mini-Sentinel Distributed Database (MSDD) and among members with a pre-existing condition of atrial fibrillation and atrial flutter. Data from July 1, 2011 to September 30, 2013 from 18 Data Partners contributing to the MSDD were included in this request. The request was distributed to Data Partners on November 22, 2013. Read More Deliverables (1)Mini-Sentinel Modular Program Report: Incident Use of RivaroxabanAdditional InformationAdditional DetailsFDA Center: CDERTime Period: July 1, 2011 - September 30, 2013Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All individualsData Sources: Mini-Sentinel Distributed Database (MSDD)
